{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:11:56Z","timestamp":1780391516762,"version":"3.54.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48200-3","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T21:57:04Z","timestamp":1775858224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metformin treatment impairs the adenine nucleotide translocator activity and energy metabolism in human clear cell renal carcinoma cells"],"prefix":"10.1038","volume":"16","author":[{"given":"Lidia","family":"de Bari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano Francesco","family":"Caratozzolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Petrosillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriana","family":"Cal\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Antognelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Armeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Scir\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikl\u00f3s P\u00e9ter","family":"Kalapos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"48200_CR1","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1158\/2159-8290.CD-20-0844","volume":"10","author":"SM Fendt","year":"2020","unstructured":"Fendt, S. M., Frezza, C. & Erez, A. Targeting metabolic plasticity and flexibility dynamics for cancer therapy. Cancer Discov. 10, 1797\u20131807 (2020).","journal-title":"Cancer Discov"},{"key":"48200_CR2","doi-asserted-by":"crossref","first-page":"891652","DOI":"10.3389\/fonc.2022.891652","volume":"12","author":"TB Emran","year":"2022","unstructured":"Emran, T. B. et al. Multidrug resistance in cancer: Understanding molecular mechanisms, immunoprevention and therapeutic approaches. Front. Oncol. 12, 891652 (2022).","journal-title":"Front. Oncol."},{"key":"48200_CR3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41573-022-00615-z","volume":"2","author":"H Jin","year":"2023","unstructured":"Jin, H., Wang, L. & Bernards, R. Rational combinations of targeted cancer therapies: Background, advances and challenges. Nat. Rev. Drug Discov. 2, 213\u2013234 (2023).","journal-title":"Nat. Rev. Drug Discov"},{"key":"48200_CR4","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41574-023-00833-4","volume":"19","author":"M Foretz","year":"2023","unstructured":"Foretz, M., Guigas, B. & Viollet, B. Metformin: Update on mechanisms of action and repurposing potential. Nat. Rev. Endocrinol. 19, 460\u2013476 (2023).","journal-title":"Nat. Rev. Endocrinol."},{"key":"48200_CR5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrendo.2013.256","volume":"10","author":"I Pernicova","year":"2014","unstructured":"Pernicova, I. & Korbonits, M. Metformin\u2013mode of action and clinical implications for diabetes and cancer. Nat. Rev. Endocrinol. 10, 143\u2013156 (2014).","journal-title":"Nat. Rev. Endocrinol."},{"key":"48200_CR6","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00125-017-4372-6","volume":"60","author":"BM Heckman-Stoddard","year":"2017","unstructured":"Heckman-Stoddard, B. M., DeCensi, A., Sahasrabuddhe, V. V. & Ford, L. G. Repurposing metformin for the prevention of cancer and cancer recurrence. Diabetologia 60, 1639\u20131647 (2017).","journal-title":"Diabetologia"},{"key":"48200_CR7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-med-062613-093128","volume":"66","author":"DR Morales","year":"2015","unstructured":"Morales, D. R. & Morris, A. D. Metformin in cancer treatment and prevention. Annu. Rev. Med. 66, 17\u201329 (2015).","journal-title":"Annu. Rev. Med."},{"key":"48200_CR8","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pharmthera.2011.09.004","volume":"133","author":"A Aljada","year":"2012","unstructured":"Aljada, A. & Mousa, S. A. Metformin and neoplasia: Implications and indications. Pharmacol. Ther. 133, 108\u2013115 (2012).","journal-title":"Pharmacol. Ther."},{"key":"48200_CR9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2741\/4484","volume":"22","author":"B Lan","year":"2017","unstructured":"Lan, B. et al. Metformin suppresses CRC growth by inducing apoptosis via ADORA1. Front. Biosci. (Landmark Ed). 22, 248\u2013257 (2017).","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"48200_CR10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ctrv.2017.01.005","volume":"4","author":"M Peng","year":"2017","unstructured":"Peng, M. et al. Combination of metformin with chemotherapeutic drugs via different molecular mechanisms. Cancer Treat. Rev. 4, 24\u201333 (2017).","journal-title":"Cancer Treat. Rev."},{"key":"48200_CR11","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1093\/annonc\/mdw410","volume":"27","author":"C Coyle","year":"2016","unstructured":"Coyle, C., Cafferty, F. H., Vale, C. & Langley, R. E. Metformin as an adjuvant treatment for cancer: A systematic review and meta analysis. Ann. Oncol. 27, 2184\u20132195 (2016).","journal-title":"Ann. Oncol."},{"key":"48200_CR12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.phrs.2015.06.014","volume":"101","author":"JA Jara","year":"2015","unstructured":"Jara, J. A. & L\u00f3pez-Mu\u00f1oz, R. Metformin and cancer: Between the bioenergetic disturbances and the antifolate activity. Pharmacol. Res. 101, 102\u2013108 (2015).","journal-title":"Pharmacol. Res."},{"key":"48200_CR13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/CS20110386","volume":"122","author":"B Viollet","year":"2012","unstructured":"Viollet, B. et al. Cellular and molecular mechanisms of metformin: An overview. Clin. Sci. (Lond). 122, 253\u2013270 (2012).","journal-title":"Clin. Sci. (Lond)"},{"key":"48200_CR14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1074\/jbc.275.1.223","volume":"275","author":"MY El-Mir","year":"2000","unstructured":"El-Mir, M. Y. et al. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J. Biol. Chem. 275, 223\u2013228 (2000).","journal-title":"J. Biol. Chem."},{"issue":"Pt 3","key":"48200_CR15","first-page":"607","volume":"3","author":"MR Owen","year":"2000","unstructured":"Owen, M. R., Doran, E. & Halestrap, A. P. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J. 348 Pt. 3 (Pt 3), 607\u2013614 (2000).","journal-title":"Biochem J. 348 Pt"},{"key":"48200_CR16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2049-3002-2-12","volume":"2","author":"S Andrzejewski","year":"2014","unstructured":"Andrzejewski, S., Gravel, S. P., Pollak, M. & St-Pierre, J. Metformin directly acts on mitochondria to alter cellular bioenergetics. Cancer Metab. 2, 12 (2014).","journal-title":"Cancer Metab."},{"key":"48200_CR17","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.3390\/ijms21093240","volume":"21","author":"L Agius","year":"2020","unstructured":"Agius, L., Ford, B. E. & Chachra, S. S. The metformin mechanism on gluconeogenesis and AMPK activation: The metabolite perspective. Int. J. Mol. Sci. 21, 3240 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"48200_CR18","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature13270","volume":"510","author":"AK Madiraju","year":"2014","unstructured":"Madiraju, A. K. et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 510, 542\u2013546 (2014).","journal-title":"Nature"},{"key":"48200_CR19","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1038\/sj.onc.1211024","volume":"27","author":"I Ben Sahra","year":"2008","unstructured":"Ben Sahra, I. et al. The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level. Oncogene 27, 3576\u20133586 (2008).","journal-title":"Oncogene"},{"key":"48200_CR20","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.bbamem.2008.04.011","volume":"1778","author":"M Klingenberg","year":"2008","unstructured":"Klingenberg, M. The ADP and ATP transport in mitochondria and its carrier. Biochim. Biophys. Acta. 1778, 1978\u20132021 (2008).","journal-title":"Biochim. Biophys. Acta"},{"key":"48200_CR21","doi-asserted-by":"crossref","first-page":"220198","DOI":"10.1098\/rsob.220198","volume":"12","author":"I Kurelac","year":"2022","unstructured":"Kurelac, I. et al. NDUFS3 knockout cancer cells and molecular docking reveal specificity and mode of action of anticancer respiratory complex I inhibitors. Open. Biol. 12, 220198 (2022).","journal-title":"Open. Biol."},{"key":"48200_CR22","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1124\/dmd.112.044875","volume":"40","author":"JW Higgins","year":"2012","unstructured":"Higgins, J. W., Bedwell, D. W. & Zamek-Gliszczynski, M. J. Ablation of both organic cation transporter (OCT)1 and OCT2 alters metformin pharmacokinetics but has no effect on tissue drug exposure and pharmacodynamics. Drug Metab. Dispos. 40, 1170\u20131177 (2012).","journal-title":"Drug Metab. Dispos."},{"key":"48200_CR23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/clpt.2012.210","volume":"93","author":"SL Stocker","year":"2013","unstructured":"Stocker, S. L. et al. The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin. Clin. Pharmacol. Ther. 93, 186\u2013194 (2013).","journal-title":"Clin. Pharmacol. Ther."},{"key":"48200_CR24","doi-asserted-by":"crossref","first-page":"20435","DOI":"10.1074\/jbc.M114.567271","volume":"289","author":"J Cao","year":"2014","unstructured":"Cao, J. et al. Low concentrations of metformin suppress glucose production in hepatocytes through AMP-activated protein kinase (AMPK). J. Biol. Chem. 289, 20435\u201320446 (2014).","journal-title":"J. Biol. Chem."},{"key":"48200_CR25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41586-022-04431-8","volume":"603","author":"T Ma","year":"2022","unstructured":"Ma, T. et al. Low-dose metformin targets the lysosomal AMPK pathway through PEN2. Nature 603, 159\u2013165 (2022).","journal-title":"Nature"},{"key":"48200_CR26","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(09)60229-4","volume":"373","author":"I Rini","year":"2009","unstructured":"Rini, I. & Campbell, C. Escudier,\u2008B.\u2008Renal cell carcinoma. Lancet 373, 1119\u20131132 (2009).","journal-title":"Lancet"},{"key":"48200_CR27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","volume":"499","author":"Cancer Genome Atlas Research Network","year":"2013","unstructured":"Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499, 43\u201349 (2013).","journal-title":"Nature"},{"key":"48200_CR28","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.cmet.2018.07.020","volume":"28","author":"KD Courtney","year":"2018","unstructured":"Courtney, K. D. et al. Isotope tracing of human clear cell renal cell carcinomas demonstrates suppressed glucose oxidation in vivo. Cell. Metab. 28, 793\u2013800 (2018). e2.","journal-title":"Cell. Metab."},{"key":"48200_CR29","doi-asserted-by":"crossref","first-page":"111454","DOI":"10.1016\/j.biopha.2021.111454","volume":"138","author":"A Song","year":"2021","unstructured":"Song, A., Zhang, C. & Meng, X. Mechanism and application of metformin in kidney diseases: An update. Biomed. Pharmacother. 138, 111454 (2021).","journal-title":"Biomed. Pharmacother"},{"key":"48200_CR30","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.urolonc.2011.01.003","volume":"31","author":"J Liu","year":"2013","unstructured":"Liu, J. et al. Metformin inhibits renal cell carcinoma in vitro and in vivo xenograft. Urol. Oncol. 31, 264\u2013270 (2013).","journal-title":"Urol. Oncol."},{"key":"48200_CR31","unstructured":"Li, M. et al. Effect of metformin on apoptosis of renal cell carcinoma cells in vitro and its mechanisms. Nan Fang Yi Ke Da Xue Xue Bao. 31, 1504\u20131508 (2011) (Chinese)."},{"key":"48200_CR32","doi-asserted-by":"crossref","first-page":"7446","DOI":"10.18632\/oncotarget.2081","volume":"5","author":"MF Caratozzolo","year":"2014","unstructured":"Caratozzolo, M. F. et al. TRIM8 anti-proliferative action against chemo-resistant renal cell carcinoma. Oncotarget 5, 7446\u20137457 (2014).","journal-title":"Oncotarget"},{"key":"48200_CR33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12943-017-0634-7","volume":"16","author":"F Mastropasqua","year":"2017","unstructured":"Mastropasqua, F. et al. TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours. Mol. Cancer. 16, 67 (2017).","journal-title":"Mol. Cancer"},{"key":"48200_CR34","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/ki.1994.6","volume":"45","author":"MJ Ryan","year":"1994","unstructured":"Ryan, M. J. et al. HK-2: An immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int. 45, 48\u201357 (1994).","journal-title":"Kidney Int."},{"key":"48200_CR35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10863-015-9631-y","volume":"47","author":"D Valenti","year":"2015","unstructured":"Valenti, D., Vacca, R. A. & De Bari, L. 3-Bromopyruvate induces rapid human prostate cancer cell death by affecting cell energy metabolism, GSH pool and the glyoxalase system. J. Bioenerg Biomembr. 47, 493\u2013506 (2015).","journal-title":"J. Bioenerg Biomembr."},{"key":"48200_CR36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12935-017-0464-0","volume":"17","author":"J Hastings","year":"2017","unstructured":"Hastings, J. & Kenealey, J. Avenanthramide-C reduces the viability of MDA-MB-231 breast cancer cells through an apoptotic mechanism. Cancer Cell. Int. 17, 93 (2017).","journal-title":"Cancer Cell. Int."},{"key":"48200_CR37","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.freeradbiomed.2008.09.031","volume":"46","author":"G Petrosillo","year":"2009","unstructured":"Petrosillo, G., Matera, M., Moro, N., Ruggiero, F. M. & Paradies, G. Mitochondrial complex I dysfunction in rat heart with aging: Critical role of reactive oxygen species and cardiolipin. Free Radic Biol. Med. 46, 88\u201394 (2009).","journal-title":"Free Radic Biol. Med."},{"key":"48200_CR38","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.febslet.2013.01.011","volume":"587","author":"L de Bari","year":"2013","unstructured":"de Bari, L., Moro, L. & Passarella, S. Prostate cancer cells metabolize D-lactate inside mitochondria via a D-lactate dehydrogenase which is more active and highly expressed than in normal cells. FEBS Lett. 587, 467\u2013473 (2013).","journal-title":"FEBS Lett."},{"key":"48200_CR39","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1042\/BJ20100581","volume":"431","author":"D Valenti","year":"2010","unstructured":"Valenti, D. et al. Impairment of F1F0-ATPase, adenine nucleotide translocator and adenylate kinase causes mitochondrial energy deficit in human skin fibroblasts with chromosome 21 trisomy. Biochem. J. 431, 299\u2013310 (2010).","journal-title":"Biochem. J."},{"key":"48200_CR40","doi-asserted-by":"crossref","unstructured":"Lohr, G. W. & Waller, H. D. Glucose-6-phosphate dehydrogenase. In: Bergmeyer HV (ed) Methods of enzymatic analysis. Weinheim, Verlag Chemie GmbH. 744\u2013751 (1963).","DOI":"10.1016\/B978-0-12-395630-9.50135-3"},{"key":"48200_CR41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cca.2006.05.034","volume":"374","author":"P B\u00e9nit","year":"2006","unstructured":"B\u00e9nit, P. et al. Three spectrophotometric assays for the measurement of the five respiratory chain complexes in minuscule biological samples. Clin. Chim. Acta. 374, 81\u201386 (2006).","journal-title":"Clin. Chim. Acta"},{"key":"48200_CR42","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0021-9258(19)44380-9","volume":"248","author":"GE Lienhard","year":"1973","unstructured":"Lienhard, G. E. & Secemski, I. I. P1,P5-Di(adenosine-5\u2019)pentaphosphate, a potent multisubstrate inhibitor of adenylate kinase. J. Biol. Chem. 248, 1121\u20131123 (1973).","journal-title":"J. Biol. Chem."},{"key":"48200_CR43","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/abio.2002.5698","volume":"306","author":"NC Yang","year":"2002","unstructured":"Yang, N. C., Ho, W. M., Chen, Y. H. & Hu, M. L. A convenient one-step extraction of cellular ATP using boiling water for the luciferin luciferase assay of ATP. Anal. Biochem. 306, 323\u2013327 (2002).","journal-title":"Anal. Biochem."},{"key":"48200_CR44","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/0304-3940(88)90499-5","volume":"86","author":"W Walz","year":"1988","unstructured":"Walz, W. & Mukerji, S. Lactate production and release in cultured astrocytes. Neurosci. Lett. 86, 296\u2013300 (1988).","journal-title":"Neurosci. Lett."},{"key":"48200_CR45","first-page":"2529","volume":"11","author":"M Yang","year":"2021","unstructured":"Yang, M. et al. Inhibition of mitochondrial function by metformin increases glucose uptake, glycolysis and GDF-15 release from intestinal cells. Sci. Adv. 11, 2529 (2021).","journal-title":"Sci. Adv."},{"key":"48200_CR46","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.celrep.2019.09.070","volume":"29","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. Metformin improves mitochondrial respiratory activity through activation of AMPK. Cell. Rep. 29, 1511\u20131523 (2019). e5.","journal-title":"Cell. Rep."},{"issue":"Pt 2","key":"48200_CR47","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1042\/bj20020139","volume":"365","author":"L de Bari","year":"2002","unstructured":"de Bari, L., Atlante, A., Guaragnella, N., Principato, G. & Passarella, S. D-Lactate transport and metabolism in rat liver mitochondria. Biochem. J. 365 (Pt 2), 391\u2013403 (2002).","journal-title":"Biochem. J."},{"key":"48200_CR48","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1471-4159.2006.03820.x","volume":"97","author":"A Atlante","year":"2006","unstructured":"Atlante, A. et al. Caspase-dependent alteration of the ADP\/ATP translocator triggers the mitochondrial permeability transition which is not required for the low-potassium dependent apoptosis of cerebellar granule cells. J. Neurochem. 97, 1166\u20131181 (2006).","journal-title":"J. Neurochem"},{"key":"48200_CR49","doi-asserted-by":"crossref","first-page":"2245168","DOI":"10.1080\/14756366.2023.2245168","volume":"38","author":"A Pesaresi","year":"2023","unstructured":"Pesaresi, A. Mixed and non-competitive enzyme inhibition: Underlying mechanisms and mechanistic irrelevance of the formal two-site model. J. Enzyme Inhib. Med. Chem. 38, 2245168 (2023).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"48200_CR50","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.tcb.2016.08.009","volume":"27","author":"M Salazar-Roa","year":"2017","unstructured":"Salazar-Roa, M. & Malumbres, M. Fueling the cell division cycle. Trends Cell. Biol. 27, 69\u201381 (2017).","journal-title":"Trends Cell. Biol."},{"key":"48200_CR51","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12915-014-0082-4","volume":"12","author":"A Luengo","year":"2014","unstructured":"Luengo, A., Sullivan, L. B. & Vander Heiden, M. G. Understanding the complex-I-ty of metformin action: Limiting mitochondrial respiration to improve cancer therapy. BMC Biol. 12, 82 (2014).","journal-title":"BMC Biol."},{"key":"48200_CR52","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1158\/1535-7163.MCT-18-0766","volume":"18","author":"JT The","year":"2019","unstructured":"The, J. T., Zhu, W. L., Newgard, C. B., Casey, P. J. & Wang, M. Respiratory capacity and reserve predict cell sensitivity to mitochondria inhibitors: Mechanism based markers to identify metformin-responsive cancers. Mol. Cancer Ther. 18, 693\u2013705 (2019).","journal-title":"Mol. Cancer Ther."},{"key":"48200_CR53","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.redox.2017.08.018","volume":"14","author":"AR Cameron","year":"2018","unstructured":"Cameron, A. R. et al. Metformin selectively targets redox control of complex I energy transduction. Redox Biol. 14, 187\u2013197 (2018).","journal-title":"Redox Biol."},{"key":"48200_CR54","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3390\/biom9030113","volume":"9","author":"M Pasha","year":"2019","unstructured":"Pasha, M., Sivaraman, S. K., Frantz, R., Agouni, A. & Munusamy, S. Metformin induces different responses in clear cell renal cell carcinoma caki cell lines. Biomolecules 9, 113 (2019).","journal-title":"Biomolecules"},{"key":"48200_CR55","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1038\/emm.2016.16","volume":"48","author":"J Kim","year":"2016","unstructured":"Kim, J., Yang, G., Kim, Y., Kim, J. & Ha, J. AMPK activators: Mechanisms of action and physiological activities. Exp. Mol. Med. 48, e224 (2016).","journal-title":"Exp. Mol. Med."},{"key":"48200_CR56","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/onc.2010.483","volume":"30","author":"C Algire","year":"2011","unstructured":"Algire, C. et al. Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo. Oncogene 30, 1174\u20131182 (2011).","journal-title":"Oncogene"},{"key":"48200_CR57","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1158\/2159-8290.CD-12-0263","volume":"2","author":"MN Pollak","year":"2012","unstructured":"Pollak, M. N. Investigating metformin for cancer prevention and treatment: The end of the beginning. Cancer Discov. 2, 778\u2013790 (2012).","journal-title":"Cancer Discov"},{"key":"48200_CR58","doi-asserted-by":"crossref","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","volume":"3","author":"JJ Hsieh","year":"2017","unstructured":"Hsieh, J. J. et al. Renal cell carcinoma. Nat. Rev. Dis. Primers. 3, 17009 (2017).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"48200_CR59","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","volume":"330","author":"JMM Evans","year":"2005","unstructured":"Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R. & Morris, A. D. Metformin and reduced risk of cancer in diabetic patients. BMJ 330, 1304\u20131305 (2005).","journal-title":"BMJ"},{"key":"48200_CR60","doi-asserted-by":"crossref","first-page":"101517","DOI":"10.1016\/j.redox.2020.101517","volume":"34","author":"N Apostolova","year":"2020","unstructured":"Apostolova, N. et al. Mechanisms of action of metformin in type 2 diabetes: Effects on mitochondria and leukocyte-endothelium interactions. Redox Biol. 34, 101517 (2020).","journal-title":"Redox Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48200-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48200-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48200-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:29:13Z","timestamp":1780388953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48200-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48200"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48200-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7582770\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16870"}}